Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.
about
Inflammation in irritable bowel syndrome: Myth or new treatment target?The quest for biomarkers in IBS-where should it lead us?Biomarkers of Irritable Bowel SyndromeFood allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivityIBS-like symptoms in patients with ulcerative colitisEfficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysisRifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic DichotomyEffects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndromeEffect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.A role for the gut microbiota in IBS.Human Intestinal Barrier Function in Health and DiseaseLow prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea.Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.Evidence-based clinical practice guidelines for irritable bowel syndrome.Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.Essential role of mast cells in the visceral hyperalgesia induced by T. spiralis infection and stress in rats.Bidirectional Association between Asthma and Irritable Bowel Syndrome: Two Population-Based Retrospective Cohort Studies.A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.Drug development for the irritable bowel syndrome: current challenges and future perspectivesFecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndromeChronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact ScaleAnalysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III CriteriaLack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study.Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis.Treatment of abdominal pain in irritable bowel syndrome.Immune dysregulation in the functional gastrointestinal disorders.Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.Smoking in Irritable Bowel Syndrome: A Systematic Review.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function.The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care.Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis.The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study.Chronic intractable diarrhea caused by gastrointestinal mastocytosis.General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study.Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy.Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism.Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
P2860
Q26768545-127C184F-E9DD-4E31-83A2-8AA2D98AA467Q27024239-574A55BB-96D2-4775-83D3-B2144B675B70Q28069902-04F71ADB-17BF-4BC8-9E65-F832655ED8B2Q28087731-DAE98AE0-E25D-4C57-AAFA-DC96E8E832B3Q28088663-3AB045B0-474F-4E02-B511-D59CDD79C914Q28244815-BD01847E-6D18-4F15-9143-6BB920CDD204Q31142368-20FE40CB-1359-49EF-B1A5-D3E01DBEABA2Q33469991-FEF9F455-829C-4B70-8CE3-C53874E50BEFQ33578069-89665F30-93AA-4DFA-99BF-6D2493715D89Q33917011-8FF4CCFA-D9EC-45B0-B491-BB5F1BEB6763Q34129435-A2B21CB1-AF95-4C66-979D-F4BFAB60FE75Q34416297-DA035E3E-69A5-4253-9A9F-6316EE3C9542Q34679342-9C4B16A7-3404-4728-A598-E9819F22FC30Q34709083-C572E003-90CE-4B3E-9DE0-65F167AF1D15Q35003407-DDD1BC3D-683B-4416-A2E4-0ACA5E0B3E22Q35513973-176D35A8-EAFF-4730-92DD-AFC073EBDDF2Q35590592-7D46C84F-7066-491A-8E36-42077AB34604Q35865269-4A633936-BB31-46CF-B500-E49350805859Q35993672-4EA29613-9DFC-447F-BD6E-32732E3F6F65Q36510964-FC825C47-E3BD-40B3-8E38-9D4A65503E4EQ36579818-3D6A1A1A-628F-42AE-AF17-07A78086C7FAQ36848187-819A334A-CC33-4ADF-889F-91BFBF648FC0Q36996557-C6335832-D161-4D31-B241-2D13930F6030Q37058969-6D3EC17E-D9E8-48DF-9BAA-EBE1F0734A05Q37140210-347A5CF1-A170-4764-887D-BF685354B3F2Q38087565-D7ED89FB-98EC-4E5D-96EB-1F5D751CD938Q38213185-70BCD67E-46B0-4F4E-AF40-97B5EE0E8C88Q38601401-984DC98D-9894-45F6-8CEC-1B1177B7D0E6Q38692607-3207B6AA-71E4-4CA4-B6E8-D6EDE546D436Q38727941-1545122A-03E6-49D8-AF34-C73447BFE7C6Q38765085-6199AEC1-91D2-4E1E-8B19-E86433C7181DQ39154995-373BCDBF-6D76-4552-A842-5182F732E4A8Q40202534-40DA9C97-9F33-4946-969C-2C50BE2BB16FQ40839319-B1D91D3E-F07F-474C-9F14-0FDD9254C53CQ41009017-FAD8D1DF-76F5-4553-819E-56A2E514010DQ42126928-4CE5C24C-A5F4-4B11-A99F-E438E3C9A8C4Q42695425-64A70606-9DB4-4D29-A4B4-799FD096DD36Q44180223-8B659FF8-61BD-4159-ABDD-6D9510E01F4BQ44572735-7D86E729-1620-430A-9DB0-0E03EBE33A0BQ44652662-8991AFB5-7471-4E35-9B0B-B81F95B9350F
P2860
Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en-gb
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@nl
type
label
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en-gb
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@nl
prefLabel
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en-gb
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@nl
P2860
P1476
Mucosal inflammation as a pote ...... syndrome: a systematic review.
@en
P2093
Nicholas J Talley
P2860
P304
P356
10.1007/S00535-011-0379-9
P577
2011-02-18T00:00:00Z